CORRECTED PROOF Is P2Y12 inhibitor therapy associated with an increased risk of cancer? https://doi.org/10.1093/ehjcvp/pvz003 Published: 18 January 2019 Article history Cite Permissions acute coronary syndromes antiplatelet agents ischemia coronary arteriosclerosis blood platelets cancer cardiovascular system united states food and drug administration guidelines cancer risk triton-timi 38 trial basic science research risk of excessive or recurrent bleeding european society of cardiology dapt study dual antiplatelet therapy
